SCHEMBL21705050

SCHEMBL21705050

Fc1cccc(-c2ccccc2-c2c3c(c(-c4ccccc4)c4cc5ccccc5cc24)-c2ccc4c5ccc6c7c(-c8ccccc8)c8cccc9c%10ccccc%10c(c89)c7c7ccc(c8ccc-3c2c48)c5c67)c1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP1B1 Q16678 2/20 0.32
PRKDC P78527 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
CDC7 O00311 1/20 0.32
ROCK2 O75116 1/20 0.32
MAP4K4 O95819 1/20 0.32
PIM1 P11309 1/20 0.32
PRKACA P17612 1/20 0.32
CDK2 P24941 1/20 0.32
GSK3B P49841 1/20 0.32
HIPK2 Q9H2X6 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21705051 0.88 GPR84 (0.35) CYP1A1CYP1A2CYP1B1ESR1ESR2
SCHEMBL21704892 0.87 CYP1A2 (0.33) ADORA2ACYP1A2ABCG2ESR1ESR2
SCHEMBL21704887 0.86 CYP1A2 (0.36) CYP1A1CYP1A2CYP1B1PRKDCESR1
SCHEMBL13932257 0.86 CDC7 (0.38) ADORA2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL21699099 0.85 ESR1 (0.32) ABCG2ESR1ESR2
SCHEMBL21705107 0.83 CYP1A2 (0.34) CYP1A1CYP1A2CYP1B1KDM4EHPGD
SCHEMBL21704893 0.83 CYP1A2 (0.37) CYP1A2ESR1ESR2
SCHEMBL13932268 0.83 CDC7 (0.36) ADORA2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL13932319 0.82 GPR84 (0.38) CYP1A2ESR1ESR2KDM4EHPGD
SCHEMBL21704888 0.81 SMN1; SMN2 (0.40) CYP1A2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object CANON KABUSHIKI KAISHA (JP) 2022-06-28 US disclosed
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT CANON KABUSHIKI KAISHA (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT OCIAD1, L1CAM, SPIN4 ADORA2A 4292/4885CYP1A1 429/4885CYP1A2 1327/4885
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object OCIAD1, L1CAM, SPIN4 ADORA2A 4292/4885CYP1A1 429/4885CYP1A2 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.